1. Home
  2. CBK vs PBYI Comparison

CBK vs PBYI Comparison

Compare CBK & PBYI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

CBK

Commercial Bancgroup Inc.

HOLD

Current Price

$32.93

Market Cap

392.4M

Sector

Finance

ML Signal

HOLD

Logo Puma Biotechnology Inc

PBYI

Puma Biotechnology Inc

HOLD

Current Price

$7.99

Market Cap

434.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CBK
PBYI
Founded
1975
2010
Country
United States
United States
Employees
298
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
392.4M
434.2M
IPO Year
N/A
2011

Fundamental Metrics

Financial Performance
Metric
CBK
PBYI
Price
$32.93
$7.99
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
92.9K
376.3K
Earning Date
04-27-2026
05-07-2026
Dividend Yield
1.40%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$27,685,000.00
Revenue This Year
$11.67
N/A
Revenue Next Year
$8.05
N/A
P/E Ratio
$9.10
N/A
Revenue Growth
N/A
N/A
52 Week Low
$23.24
$3.03
52 Week High
$34.46
$8.75

Technical Indicators

Market Signals
Indicator
CBK
PBYI
Relative Strength Index (RSI) N/A N/A
Support Level N/A N/A
Resistance Level N/A N/A
Average True Range (ATR) 0.00 0.00
MACD 0.00 0.00
Stochastic Oscillator 0.00 0.00

Price Performance

Historical Comparison
CBK
PBYI

About CBK Commercial Bancgroup Inc.

Commercial Bancgroup Inc is a bank holding company. Through its subsidiary, it operates as a full-service community banking institution offering traditional consumer and commercial products and services to businesses and individuals in select markets in Kentucky, North Carolina, and Tennessee. In Tennessee, its service areas include the metropolitan statistical areas of Nashville Davidson, Murfreesboro, Franklin, Knoxville, and the Tri Cities region of Kingsport, Bristol, and Johnson City, as well as Claiborne County, Cocke County, Union County, Hamblen County, and their surrounding areas.

About PBYI Puma Biotechnology Inc

Puma Biotechnology Inc is a biopharmaceutical company that develops and commercializes inventive products to enhance cancer care and improve treatment outcomes for patients. It is currently commercializing NERLYNX, an oral version of neratinib, for the treatment of HER2-positive breast cancer. Also, it is developing Alisertib, a selective, small-molecule inhibitor of aurora kinase A that is designed to disrupt mitosis, resulting in apoptosis of rapidly proliferating tumor cells that are dependent on aurora kinase A.

Share on Social Networks: